Cargando…
Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models
The artemisinin family of compounds is cytopathic in certain cancer cell lines that are positive for human papillomaviruses (HPV) and can potentially drive the regression of dysplastic lesions. We evaluated the efficacy of topical dihydroartemisinin (DHA) on cervical dysplasia and anal dysplasia in...
Autores principales: | Gunder, Laura C., Blaine-Sauer, Simon, Johnson, Hillary R., Shin, Myeong-Kyun, Auyeung, Andrew S., Zhang, Wei, Leverson, Glen E., Ward-Shaw, Ella T., King, Renee E., McGregor, Stephanie M., Matkowskyj, Kristina A., Lambert, Paul F., Carchman, Evie H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332511/ https://www.ncbi.nlm.nih.gov/pubmed/35893697 http://dx.doi.org/10.3390/v14081632 |
Ejemplares similares
-
A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus
por: Blaine-Sauer, Simon, et al.
Publicado: (2021) -
Systemic Delivery of a Dual PI3K/mTOR Inhibitor More Effective than Topical Delivery in Preventing Anal Carcinogenesis in an HPV Transgenic Mouse Model
por: Gunder, Laura C, et al.
Publicado: (2022) -
Dysregulation of Autophagy Contributes to Anal Carcinogenesis
por: Carchman, Evie H., et al.
Publicado: (2016) -
Anogenital-Associated Papillomaviruses in Animals: Focusing on Bos taurus Papillomaviruses
por: Yamashita-Kawanishi, Nanako, et al.
Publicado: (2020) -
Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease
por: Gunder, Laura C., et al.
Publicado: (2023)